600276.SS
Price:
$51.84
Market Cap:
$328.64B
Jiangsu Hengrui Medicine Co., Ltd., a pharmaceutical company, researches, develops, manufactures, and commercializes medicine worldwide. The company is developing Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403 for oncology, metabolic, pain, autoimmune, and other indications. The company was founded in 1970 and is based in Lianyungang, China.
Industry
Drug Manufacturers - General
IPO Date
2000-10-18
Stock Exchange
SHH
Ticker
600276.SS
According to Jiangsu Hengrui Medicine Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 48.00. This represents a change of 5.07% compared to the average of 45.68 of the last 4 quarters.
The mean historical PE Ratio of Jiangsu Hengrui Medicine Co., Ltd. over the last ten years is 58.12. The current 48.00 PE Ratio has changed 8.16% with respect to the historical average. Over the past ten years (40 quarters), 600276.SS's PE Ratio was at its highest in in the December 2021 quarter at 250.42. The PE Ratio was at its lowest in in the March 2016 quarter at 28.41.
Average
58.12
Median
56.32
Minimum
34.35
Maximum
93.29
Discovering the peaks and valleys of Jiangsu Hengrui Medicine Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 50.68%
Maximum Annual PE Ratio = 93.29
Minimum Annual Increase = -30.99%
Minimum Annual PE Ratio = 34.35
Year | PE Ratio | Change |
---|---|---|
2024 | 45.90 | -30.99% |
2023 | 66.51 | 5.92% |
2022 | 62.80 | -12.07% |
2021 | 71.42 | -23.44% |
2020 | 93.29 | 29.06% |
2019 | 72.29 | 50.68% |
2018 | 47.97 | -3.74% |
2017 | 49.84 | 45.09% |
2016 | 34.35 | -6.73% |
2015 | 36.83 | 43.05% |
The current PE Ratio of Jiangsu Hengrui Medicine Co., Ltd. (600276.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
58.40
5-year avg
67.99
10-year avg
58.12
Jiangsu Hengrui Medicine Co., Ltd.’s PE Ratio is greater than China Tourism Group Duty Free Corporation Limited (32.13), greater than Kweichow Moutai Co., Ltd. (20.13), greater than Foshan Haitian Flavouring and Food Company Ltd. (33.59), greater than Wuliangye Yibin Co.,Ltd. (13.99), greater than Midea Group Co., Ltd. (13.01),
Company | PE Ratio | Market cap |
---|---|---|
32.13 | $118.38B | |
20.13 | $1.79T | |
33.59 | $224.20B | |
13.99 | $456.89B | |
13.01 | $559.75B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jiangsu Hengrui Medicine Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Jiangsu Hengrui Medicine Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Jiangsu Hengrui Medicine Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for Jiangsu Hengrui Medicine Co., Ltd. (600276.SS)?
What is the highest PE Ratio for Jiangsu Hengrui Medicine Co., Ltd. (600276.SS)?
What is the 3-year average PE Ratio for Jiangsu Hengrui Medicine Co., Ltd. (600276.SS)?
What is the 5-year average PE Ratio for Jiangsu Hengrui Medicine Co., Ltd. (600276.SS)?
How does the current PE Ratio for Jiangsu Hengrui Medicine Co., Ltd. (600276.SS) compare to its historical average?